M42 appoints Dimitris Moulavasilis as Group CEO
Mr. Moulavasilis brings a wealth of experience to the role as a trusted leader within the M42 ecosystem. He served as Chief Executive Officer (CEO) of M42's Global Patient Care platform, a central component of M42's mission to transform healthcare on a global scale, and as CEO of Diaverum, a global renal care provider acquired by M42 in 2023. Before joining Diaverum in 2018, he was the Group Chief Executive Officer at Affidea, a leading European provider of imaging, outpatient and cancer care services. With deep institutional knowledge and a proven track record of operational leadership, innovation, digital transformation and growth, Mr. Moulavasilis' appointment ensures a seamless transition and continued momentum for M42.
The leadership transition follows a milestone chapter in M42's journey. Having led Mubadala Health after forming it as chief executive officer, including the acquisition of a 60 per cent stake in United Eastern Medical Services (UEMedical), Mr. Al Nowais was a founding figure behind the creation of M42 with the merger of Mubadala Health and G42 Healthcare in 2022. He has since played a defining role in shaping M42 into the AI-powered global health leader it is today, operating in 26 countries. Under his leadership, M42 has grown 5x in seven years, expanding internationally with the acquisition of Diaverum in 2023 and through organic growth strategies in key markets; entering local and global partnerships; and, delivering exceptional patient outcomes, with numerous UAE and regional firsts in care.
Peng Xiao, Chairman of M42 and Group Chief Executive Officer of G42, said: 'Building on the strong foundation established by Hasan, we are now entering the next chapter of M42's journey. I want to sincerely thank Hasan for his visionary leadership and unwavering dedication in shaping M42 into the powerhouse it is today. Looking ahead, we are excited to work with Dimitris, a seasoned leader with global experience, strategic depth, and a passion for innovation. His appointment marks an exciting new phase for M42 as we continue to advance the frontiers of healthcare through technology and world-class clinical excellence.'
Under Mr. Moulavasilis' leadership, M42 will remain firmly focused on its purpose-driven mission and core values, continuing to pioneer healthcare innovation from the UAE to the world. His vision will guide M42 through the next phase of its strategic growth and expansion across existing and new global markets.
Dimitris Moulavasilis, newly appointed Group CEO of M42, said: 'It is a privilege to be entrusted with writing the next chapter for M42. I am proud to build on the strong foundation laid by Hasan and the leadership team. Together with our people, partners and patients, we will continue to push the boundaries of healthcare innovation, expand our global footprint and disrupt traditional healthcare models to accelerate the shift from sickness to prevention and positively impact lives locally and globally.'
Hasan Jasem Al Nowais, current Managing Director and Group Chief Executive Officer of M42 said: 'Over the past decade, we've built on the strong foundations at Mubadala Health to create a global health leader in M42, which has improved lives across borders and continues to make innovative strides to benefit all people, leaving no-one behind. I am confident that Dimitris will continue to drive this vision forward with the same passion, purpose and relentless pursuit of excellence. I have unwavering confidence in M42's strength and readiness for the next chapter. With a strong, integrated group structure and a deep leadership bench, M42 is exceptionally well positioned for the future. I look forward to supporting Dimitris' efforts and M42 as a member of its Board.'
About M42
M42 is a global health champion powered by artificial intelligence (AI), technology and genomics to advance innovation in health for people and the planet. Headquartered in Abu Dhabi, M42 combines its specialized, state-of-the-art facilities with integrated health solutions like genomics and biobanks, and harnesses advanced technologies to deliver precise, preventive and predictive care, to impactfully disrupt traditional healthcare models and positively impact lives globally.
Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 has more than 480 facilities in 26 countries and over 20,000 employees. M42 includes renowned healthcare providers including Cleveland Clinic Abu Dhabi, Danat Al Emarat, Diaverum, Imperial College London Diabetes Centre, Sheikh Sultan bin Zayed Hospital, and Moorfields Eye Hospital Abu Dhabi. As well as operating the Emirati Genome Programme, M42 runs Abu Dhabi BioBank and Abu Dhabi Health Data Services (ADHDS), a global tech-enabled healthcare company operating Malaffi.
For media inquiries or interview opportunities, please contact:
Mazar Masud
Senior Director, Global Corporate Communications, M42
E: mmasud@m42.ae
M: +971 52 593 5926
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Etihad
an hour ago
- Al Etihad
UAE dominates Forbes list with 49 of Middle East's top 100 travel and tourism leaders
12 Aug 2025 00:08 A. SREENIVASA REDDY (ABU DHABI)A total of 49 UAE-based leaders have secured places on the 2025 list of the Middle East's Top 100 Travel & Tourism Leaders compiled by Forbes Middle East. The ranking spotlights figures driving the most ambitious destinations, hotels, airlines, airports, and tourism initiatives, and reflects the sector's rapid momentum fuelled by government strategy, record investment, and bold Highness Sheikh Ahmed bin Saeed Al Maktoum, Chairman and Chief Executive of Emirates Airline & Group, topped the list for the fourth consecutive year. Other prominent UAE-based leaders in the ranking include Saleh Mohamed Al Geziry, Director General of Tourism at DCT – Abu Dhabi, Humaid Matar Al Dhaheri, Managing Director and Group CEO of ADNEC Group; Mohamed Abdallah Al Zaabi, Group CEO of Miral; Paul Griffiths, CEO of Dubai Airports; Shaikha Nasser Al Nowais, Secretary-General Elect of the UN World Tourism Organization (UNWTO), Antonoaldo Neves, Group Chief Executive Officer of Etihad Aviation Group, Elena Sorlini, Managing Director & Chief Executive Officer of Abu Dhabi Airports, and Ghaith Al Ghaith, CEO of UAE's dominance was followed by Saudi Arabia with 24 leaders on the list, Egypt with seven, Oman with five, and Jordan and Morocco with four each. Qatar and Bahrain each contributed three leaders, while Kuwait and Tunisia had one representative apiece—from Kuwait Airways and the Tunisian National Tourist Office, Middle East said it assessed candidates from both the public and private sectors based on organisational scale—measured by revenues, asset values, hotel keys, and passenger numbers—alongside professional achievements, experience, and overall impact on the year's list also spotlighted regional milestones, including Miral's announcement of the Middle East's first Disney theme park and resort on Yas Island in Abu Dhabi, developed in partnership with The Walt Disney Company. The park will be the seventh Disney resort worldwide. Other entries reflected a focus on heritage preservation and eco-tourism, such as projects led by Saudi Arabia's Diriyah Company, Boutique Group, the Royal Commission for AlUla, and newcomer ENVI Lodges. Source: Aletihad - Abu Dhabi
Zawya
3 hours ago
- Zawya
China's BRI investments hit $124bln in H1 2025, with Middle East in strategic focus
Chinese investments under the Belt and Road Initiative (BRI) reached a record $124 billion in the first half of 2025, with the Middle East playing a leading role in deals tied to energy transition and digital infrastructure, even as construction activity in the region saw a sharp pullback. According to the 'China Belt and Road Initiative Investment Report 2025,' produced by the Griffith Asia Institute (GAI) at Griffith University in collaboration with the Green Finance & Development Centre (GFDC) of FISF, People's Republic of China, total construction activity in the Middle East declined from the previous year. Yet, Saudi Arabia and the UAE still ranked among the top five global recipients for construction volume, securing $7.2 billion and $7 billion, respectively. 'This is a short-term shift and does not explain any trends,' said Christoph Nedopil, GFDC director and author of the report, adding that the Gulf continues to remain strategically relevant for Chinese companies, particularly as BRI investments pivot toward green energy, metals processing, and high-tech manufacturing. Record surge China's BRI activity in the first half of 2025 included $66.2 billion in construction contracts and $57.1 billion in non-financial investments — nearly matching the initiative's total for all of 2024. The surge was powered by big-ticket projects in Nigeria, Kazakhstan, and Thailand across energy, mining, and technology. 'The extreme surge in H1 2025 might be explained by a few very large deals, which might have just happened in this time,' Nedopil said. 'Overall, we have seen a growing engagement trend by China in the BRI countries over the past years.' Among the drivers, he pointed to three strategic motivations: 'A stronger desire by Chinese companies to be closer to their customers and thus invest closer to the markets where they sell their goods; a desire to de-risk trade and reduce reliance on exports from China; and a need to invest in local markets to meet local content requirements (e.g., for minerals processing).' A notable development was the growing role of private Chinese enterprises in BRI deals — a marked shift from the earlier dominance of state-led megaprojects. Companies such as Longi Green Energy, East Hope Group, and Xinfa Group led outbound investment activity, including in key Gulf economies. 'The engagement by privately owned Chinese companies in BRI countries has been rising over the past years due to their stronger global positioning as technology leaders,' Nedopil explained. 'At the same time, a number of Chinese private companies have gained relevant experience to work in more difficult economic and governance environments, which is also particularly relevant in the mining sector.' Middle East's strategic fit Despite a drop in construction activity overall, the Middle East's strategic alignment with China's BRI priorities—particularly around clean energy, resource processing, and digital infrastructure—remains strong. In Saudi Arabia, Harbin Electric signed a $1.6 billion deal to construct a gas-fired power plant. Meanwhile, Egypt secured a $700 million investment from Xinyi Glass Holding to build a solar PV glass manufacturing facility, signaling expanded cooperation in clean tech manufacturing. Energy continued to dominate Chinese BRI engagement, accounting for 35 percent of the total. While green energy investments hit a new high of $9.7 billion in H1 2025, oil and gas still outpaced renewables with over $30 billion in fossil-fuel-backed deals. One of the largest was the $20 billion Ogidigbon Gas Park in Nigeria. 'Host countries need to take their responsibility on sustainable development as seriously as Chinese investors,' Nedopil said. 'Without clear agency from host countries to attract sustainable investments, Chinese partners will likely also provide non-green engagement as long as it is legal.' Beyond construction Transport-related BRI activity continued its decline, falling to just 7.2 percent of total engagement, the lowest since the initiative's launch in 2013. In contrast, sectors like technology, manufacturing, and mining gained momentum. Chinese investments in these areas more than doubled to $23.2 billion in H1 2025, fueled by demand for electric vehicles, batteries, and green hydrogen. Among the standout deals were Longi's €7.6 billion hydrogen project in Nigeria and China Aviation Lithium Battery's $2.1 billion EV battery facility in Portugal. Metals and mining also saw record engagement. China invested $24.9 billion in the sector in H1 2025, with Kazakhstan receiving the lion's share—$12 billion for aluminium and $7.5 billion for copper. IMEC vs. BRI With the India-Middle East-Europe Economic Corridor (IMEC) gathering momentum, questions remain over whether it will challenge or complement BRI's footprint in the Gulf. 'Currently, China's engagement in most countries has become less focused on transportation compared to earlier years,' said Nedopil. 'India itself is also not a BRI country. Meanwhile, over the years, many transport corridors have been worked on in this region, not least through CAREC. While IMEC was announced in 2023, the implementation of IMEC projects will strongly depend on the ability of regional players and the US to collaborate, which at this point carries some uncertainty.' Outlook: steady and strategic Looking ahead, the report forecasts a moderation in Chinese BRI engagement in the second half of 2025. Fewer megadeals are expected, but the number of deals is likely to remain strong - especially in strategic sectors. 'For the rest of 2025, we see stabilisation of Chinese BRI engagement with a focus on BRI engagement in renewable energy, mining and new technologies,' Nedopil noted in the report. He added that 'potential future engagements remain in six project types: manufacturing in new technologies (example, batteries), renewable energy, trade-enabling infrastructure (including pipelines, roads), ICT (example, data centres), resource-backed deals (example, mining, oil, gas), and high visibility or strategic projects (example, railway, ports).' With rising geopolitical and trade uncertainties, Chinese firms are expected to further diversify and deepen their overseas footprint—particularly through the so-called 'New Three' industries: EVs, batteries, and renewable energy. 'The ability of Chinese companies to expand abroad has been shifting to more private sector companies that are engaging in investment,' said Nedopil. 'They have, over the past years, acquired the capital and the know-how how to invest in overseas markets.' (Reporting by SA Kader; Editing by Anoop Menon) (
Al Etihad
3 hours ago
- Al Etihad
Renowned orthopaedic experts bring advanced care to Abu Dhabi in August
11 Aug 2025 22:33 SAMIHAH ZAMAN (ABU DHABI)Patients looking for world-class orthopaedic care close to home can benefit from a duo of doctors headed to Abu Dhabi as part of the Department of Health – Abu Dhabi's (DoH) Visiting Physicians Munjed Al Muderis, a US-based consultant in orthopaedic surgery and Singapore-based Dr. Aymeric Lim, senior consultant of hand and reconstructive microsurgery, are seeing patients at two healthcare facilities in the capital, the DoH has announced. 'The DoH welcomes top-tier doctors from around the world to the Emirate during August, offering exceptions healthcare services through the Visiting Physicians Programme,' the authority announced. Dr. Munjed Al Muderis (L) and Dr. Aymeric Lim (R) Al Muderis practises at the St Mary Hosptial, Paley Institute at West Palm Beach, one of the largest centres in orthopaedics and limb lengthening in the United States. He specialises in limb lengthening, the treatment of diabetic feet, osseointegration for amputees, limb reconstruction, joint replacement, bone tumour treatment and paediatric orthopaedics. According to the DoH, he will see patients at the Burjeel Medical City between August 11 and part of the National University Hospital in Singapore, has 30 years of experience in micro hand surgeries, nerve surgery, tendon transfer, and the treatment of patients with severe crush or nerve injuries in the forearm. He will offer treatment services at the Sheikh Shakhbout Medical City between August 11 and DoH has urged patients and their families to directly contact the respective hospitals in order to book appointments. The authority's Visiting Physicians Programme – launched in 2021 with the aim of providing world-class care in Abu Dhabi – had enabled the treatment of over 3,200 patients in the emirate as of December 2024. Source: Aletihad - Abu Dhabi
